This is the authors' abstract. We don't add key points for this paper.
We have constructed stable human immunodeficiency virus (HIV) packaging cell lines that when transfected with an HIV-based retroviral vector produce packaged vectors capable of transducing susceptible CD4+ cells. This HIV-1-based retroviral vector system has the potential for providing targeted delivery and regulated expression of immunogens or antiviral agents in CD4+ cells.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Carroll et al. (1994) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: